Figure 1: A schematic diagram that illustrates the steps involved in content generation, processing and data analysis for antigen microarrays. Antigen-specific tolerization with epitopes of oral type ...
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian ...
Medical Device Network on MSN
Vaxxas gains Australia’s TGA licence to manufacture HD microarray patch
Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical studies at a biomedical facility in ...
With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...
With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...
Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...
The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...
Roughly one-in-five U.S. teens say they are on TikTok and YouTube almost constantly. At the same time, 64% of teens say they use chatbots, including about three-in-ten who do so daily. New findings, ...
The global advanced dermatology drug delivery devices market size was US$ 3,569.9 million in 2021. The global advanced dermatology drug delivery devices market size is forecast to reach US$ 8,785.0 ...
Digital platforms are recasting the relationships between customers, workers, and employers as the silicon chip’s reach permeates almost everything we do—from buying groceries online to finding a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback